Skip to content
HowShorted

INOVIO PHARMACEUTICALS, INC. short interest in 2018

In 2018, INOVIO PHARMACEUTICALS, INC.'s disclosed short interest ran from 9.78% of shares outstanding on 12 Jan 2018 to 6.39% on 31 Dec 2018, a change of -3.39 percentage points. The year's high was 12.05% on 28 Feb 2018 and its low 5.61% on 14 Dec 2018, averaging 9.59% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.53 days on 31 Jul 2018. Full history: INOVIO PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for INOVIO PHARMACEUTICALS, INC. in 2018

2018 in figures

Start of year
9.78% (12 Jan 2018)
End of year
6.39% (31 Dec 2018)
Change
-3.39 pp
High
12.05% (28 Feb 2018)
Low
5.61% (14 Dec 2018)
Average
9.59%
Highest days to cover
16.53 (31 Jul 2018)
SEC filings marked
4

Every report in 2018

INOVIO PHARMACEUTICALS, INC. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20189.78%6.09
31 Jan 201810.43%4.42
15 Feb 201811.80%8.22
28 Feb 201812.05%14.06
15 Mar 201811.65%11.1310-K filed
29 Mar 201811.51%7.33
13 Apr 201811.39%9.77
30 Apr 201811.41%12.48
15 May 201811.53%10.0410-Q filed
31 May 201810.62%10.38
15 Jun 201811.52%12.34
29 Jun 201811.28%9.39
13 Jul 201810.68%14.19
31 Jul 201810.20%16.53
15 Aug 20189.91%12.0810-Q filed
31 Aug 20188.96%8.04
14 Sep 20188.08%7.53
28 Sep 20187.88%7.25
15 Oct 20187.81%4.84
31 Oct 20187.72%7.93
15 Nov 20186.07%6.3010-Q filed
30 Nov 20185.87%7.52
14 Dec 20185.61%6.54
31 Dec 20186.39%5.45

See also: INOVIO PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.